| Title |
|
The global implications of the gentamicin histamine contamination- sorting fact from fiction. |
|
|
| Publication Date |
|
| Author(s) |
|
| Type of document |
|
| OrcId |
|
| DOI |
|
| Abstract |
|
On the 6th of October 2017 the Therapeutics Goods Administration (TGA) in conjunction with Pfizer Australia released a statement to recall 10 batches of gentamicin Infection BP 80mg in 2ml Steriluer ampoules, due to the finding that these batches may have contained higher than expected amounts of histamine, a residual from the manufacturing process(1).…. |
|
|
| Link |
|
| Citation |
|
Antimicrobial agents and chemotherapy 2018; online first: 26 November |
|
|
| Jornal Title |
|
Antimicrobial agents and chemotherapy |
|
|
